Johnson & Johnson Vision announced the launch of its Tecnis Eyhance IOL in Europe. This next-generation monofocal IOL allows patients to experience high-quality vision at both intermediate and far distances.
“With the availability of Tecnis Eyhance IOL in Europe, we are proud to deliver another meaningful solution for patients with cataracts,” Tom Frinzi, Worldwide President, Surgical, Johnson & Johnson Vision, said in a company news release. “We saw an opportunity to build upon the legacy of the Tecnis Family of IOLs and the proven design of our 1-piece platform to reimagine what was possible with the standard aspheric monofocal IOL.”
Tecnis Eyhance IOL allows patients to achieve significantly improved intermediate vision, compared with a standard aspheric monofocal IOL, along with 20/20 distance vision. In addition, data has shown a low incidence of halo, glare, or starburst comparable to what has been reported with the Tecnis 1-piece IOL. According to patient-reported outcomes, Tecnis Eyhance IOL enables most patients to perform certain activities with greater ease, such as being able to walk on uneven surfaces, and to engage in activities of personal interest, including favorite hobbies.
“Today, patients with cataracts are forced to make a trade-off decision on their vision when selecting a monofocal intraocular lens,” Oliver Findl, MD, MBA, Chief of Department of Ophthalmology, Hanusch Hospital Vienna and ESCRS Board Member and Secretary, said in the news release. “They can have corrected vision at a distance, but require glasses for near and intermediate vision activities, which refers to everything at arm’s length such as computer work or looking at a car speedometer. Tecnis Eyhance IOL offers high quality intermediate as well as distance vision, which is an important advancement to allow patients greater ease in certain activities in their day-to-day lives.”
Tecnis Eyhance IOL has European CE Mark approval and is now commercially available across Europe, including UK, Italy, France, Spain and Germany. This product is not currently approved or commercially available in other countries. In some countries, Tecnis Eyhance IOL is covered by medical insurance making it an important option for patients when a monofocal IOL is being considered.